Provexis Plc engages in the development and commercialization of Fruitflow, an anti-thrombotic technology. The Fruitflow is a scientifically proven tomato extract which inhibits platelet aggregation. The company was founded in 1999 and is headquartered in Reading, the United Kingdom.